SAVINGS DEADLINE EXPIRES IN:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany Christine Weinl-Tenbruck, Ph.D.Senior Scientist, Dept. of Molecular Therapy at CureVac SESpeaker
Profile
2018-present Senior Scientist at CureVac SE in the Department of Molecular Therapy
2016 – 2017 Scientist at CureVac AG in the Department of Enabling Technologies
2006-2015 Postdoc at the Interfaculty Institute for Molecular and Cell Biology, University of Tuebingen, with focus on an endothelial-specific knockout mouse model of Serum Response Factor SRF
2003-2005 Postdoc at the Department of Anatomy, University of Cambridge, focusing on retinal axon guidance in the model organism Xenopus laevis
2000-2002 Dissertation at the Max-Planck-Institute for Developmental Biology, Tuebingen on retinal axon guidance
Agenda Sessions
mRNA-based Therapy Proves Superior to the Standard of Care for Treating Hereditary Tyrosinemia 1 in a Mouse Model
, 08:30View Session